HEROUT, Vladimír, Michaela HEROUTOVÁ, Zdeněk MERTA, Ivan ČUNDRLE a Kristián BRAT. Transbronchial biopsy from the upper pulmonary lobes is associated with increased risk of pneumothorax - a retrospective study. BMC Pulmonary Medicine. London: Biomed Central LTD, 2019, roč. 19, č. 56, s. 1-6. ISSN 1471-2466. Dostupné z: https://dx.doi.org/10.1186/s12890-019-0820-z.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Transbronchial biopsy from the upper pulmonary lobes is associated with increased risk of pneumothorax - a retrospective study
Autoři HEROUT, Vladimír (203 Česká republika, domácí), Michaela HEROUTOVÁ (203 Česká republika, domácí), Zdeněk MERTA (203 Česká republika, domácí), Ivan ČUNDRLE (203 Česká republika, domácí) a Kristián BRAT (703 Slovensko, garant, domácí).
Vydání BMC Pulmonary Medicine, London, Biomed Central LTD, 2019, 1471-2466.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30203 Respiratory systems
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.813
Kód RIV RIV/00216224:14110/19:00109482
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1186/s12890-019-0820-z
UT WoS 000460042200001
Klíčová slova anglicky Pneumothorax; Bronchoscopy; Transbronchial biopsy; Upper pulmonary lobe; Pleural pressure
Štítky 14110122, 14110215, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 11. 5. 2020 09:13.
Anotace
BackgroundPneumothorax (PTX) is one of the most common complications of transbronchial biopsy (TBB). Previous research suggests that upper pulmonary lobe TBB may be associated with increased risk of PTX development. The aim of this study was to compare the risk of PTX after TBB performed from different pulmonary lobes.MethodsAll bronchoscopic records from the period January 1st, 2015 - December 31st, 2017 (from the Department of Respiratory Diseases, University Hospital Brno, Czech Republic) were retrospectively analyzed. Of the 3542 bronchoscopic records, 796 patients underwent TBB and were further analyzed. Basic demographic data, TBB procedure-related factors, smoking history and radiological features were analyzed. Furthermore, in patients who developed PTX, PTX onset, PTX symptoms, distribution of the abnormal radiological findings and duration of hospitalization were also analyzed.ResultsPatients who developed PTX had significantly lower body mass index (BMI) and more than 4 samples taken during procedure (all p<0.05). TBB performed from the left upper pulmonary lobe was associated with a significant risk of PTX development (OR 2.27; 95% CI 1.18-4.35; p=0.02). On the contrary, TBB performed from the right lower lobe was associated with a significant reduction of risk of developing PTX (OR 0.47; 95% CI 0.22-0.98; p=0.04). Logistic regression analysis showed BMI (OR 1.08; 95% CI 1.02-1.16; p=0.01), left upper lobe as sampling site (OR 2.15; 95% CI 1.13-4.11; p=0.02) and more than 4 samples taken (OR 1.91; 95% CI 1.04-3.49; p=0.04) to be significantly associated with PTX development.ConclusionsWe conclude that TBB from the left upper pulmonary lobe is associated with significantly increased risk of post-procedural PTX. The right lower pulmonary lobe seems to be the safest sampling site to perform TBB. In patients with diffuse-type pulmonary disease, TBB should be performed preferably from the right lower lobe in order to decrease the risk of post-procedural PTX.
VytisknoutZobrazeno: 21. 5. 2024 11:25